Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats

Journal of Neurochemistry

Volumn 66, Issue 3, 1996, Pages 1113-1117

  Itoh, Akio ^a   Nitta, Atsumi ^a   Nadai, Masayuki ^a   Nishimura, Kyoko ^a   Hirose, Mitsuhiko ^b   Hasegawa, Takaaki ^a   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Orient Indust Hlth Associates I   (Japan)

Author keywords

Acetylcholine; Alzheimer's disease; Central nervous system; Dopamine; Rats; Amyloid protein

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ACETYLCHOLINE; AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; DOPAMINE; HOMOVANILLIC ACID;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINE RELEASE; ENZYME ACTIVITY; MALE; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; AMYLOID BETA-PROTEIN; ANIMALS; CORPUS STRIATUM; DOPAMINE; EXTRACELLULAR SPACE; FRONTAL LOBE; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; MICRODIALYSIS; NICOTINE; POTASSIUM; RATS;

EID: 0030038473     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66031113.x     Document Type: Article

References (30)

1. Brazell M. P., Mitchell S. N., Joseph M. H., and Gray J. A. (1990) Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology 29, 1177-1185.
2. Clarke P. B. S. and Pert A. (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348, 355-358.
3. Clarke P. B. S., Pert C. B., and Pert A. (1984) Autoradiographic distribution of nicotine receptors in rat brain. Brain Res. 323, 390-395.
4. Coyle J. T., Price D. L., and DeLong M. R. (1983) Alzheimer's disease: cortical cholinergic innervation. Science 219, 1184-1190.
5. Davies P. and Maloney A. J. F. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet ii, 1403.
6. Etcheberrigaray R., Ito E., Oka K., Tofel-Grehl B., Gibson G. E., and Alkon D. L. (1993) Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8209-8213.
7. + channels. Science 264, 276-279.
8. Flicker C., Dean R. L., Fischer S. K., and Bartus R. T. (1983) Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol. Biochem. Behav. 18, 973-981
9. 3H]-nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal. J. Neurochem. 47, 1948-1954
10. Hardy J. and Allsop D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Neurosci. 12, 383-388.
11. Hasegawa M., Kinoshita H., Amano M., Hasegawa T., Kameyama T., and Nabeshima T. (1993) MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysis. Neurosci. Lett. 150, 53-56.
12. Kosik K. S. (1991) Alzheimer plaques and tangles: advances on both fronts. Trends Neurosci. 14, 218-219
13. Le Conte G., Bartolini L., Casamenti F., Marconcini-Pepeu I., and Pepeu G. (1982) Lesions of cholinergic forebrain nuclei: changes in advance behavior and scopolamine actions. Pharmacol. Biochem. Behav. 17, 933-937.
14. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
15. Nabeshima T. and Nitta A. (1994) β-Amyloid protein-induced memory impairment and neuronal dysfunction animal model. Tohoku J. Exp. Med. 174, 241-249.
16. Nabeshima T., Maruyama E., Katoh A., and Kameyama T. (1991a) The effect of tacrine (THA) on cycloheximide- and basal forebrain lesion-induced memory deficit in rats. Jpn. J. Pharmacol. 57, 311-319.
17. Nabeshima T., Ogawa S., Nishimura H., Fuji K., Kameyama T., and Sasaki Y. (1991b) Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats. J. Pharmacol. Exp Ther. 257, 562-566.
18. Nitta A., Furukawa Y., Hayashi K., Hiramatsu M., Kameyama T., Hasegawa T., and Nabeshima T. (1992) Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain. Neurosci. Lett. 144, 152-156.
19. Nitta A., Murase K., Furukawa Y., Hayashi K., Hasegawa T., and Nabeshima T. (1993) Effects of oral administration of stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats. Eur. J. Pharmacol. 250, 23-30.
20. Nitta A., Itoh A., Hasegawa T., and Nabeshima T. (1994a) β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170, 63-66.
21. Nitta A , Murakami Y., Furukawa Y., Kawatsura W., Hayashi K., Yamada K., Hasegawa T., and Nabeshima T. (1994b) Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats. Naunyn Schmiedebergs Arch. Pharmacol 349, 401-407.
22. Nordberg A., Romanelli L., Sundwall A., Bianchi C., and Beani L. (1989) Effect of acute and subchronic nicotine treatment on cortical acetylcholine release and on nicotinic receptors in rats and guinea-pigs. Br. J. Pharmacol. 98, 71-78.
23. Paxinos G. and Watson C. (1986) The Rat Brain in the Stereotaxic Coordinates. Academic Press, New York.
24. Pike C. J., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
25. Rossor M. N., Garretta N J., Johnson A. L., Mountjoy C Q., Roth M., and Iversen L. L. (1982) A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105, 313-330.
26. Sims N. R., Bowen D. M., Allen S. J., Smith C. C. T., Neary D., Thomas D. J., and Davison A. N. (1983) Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem. 40, 503-509.
27. Whitehouse P. J., Price D L., Struble R. G., Clark A. W., Coyle J. T., and DeLong M. R. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215, 1237-1239.
28. Whitson J. S., Selkoe D. J., and Cotman C. W. (1989) Amyloid β protein enhances the survival of hippocampal neurons in vitro. Science 243, 1489-1490.
29. Yankner B. A., Dawes L. R., Fisher S., Villa-Komaroff L , Oster-Granite M. L., and Neve R. L. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Atzheimer's disease. Science 245, 417-420.
30. Yankner B. A., Duffy L. K., and Kirschner D. D. (1990) Neurotrophic and neurotoxic effects of amyloid β protein, reversal by tachykinin neuropeptides. Science 250, 279-282.